Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.7670 per EA under NDC 43598034530. Its NADAC has been published 342 times since Oct 17, 2018.
Strength
400 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598034530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA206547On Market Since
8/13/2018
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 342 times since Oct 17, 2018, and over the history we have for it it has declined 84.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7670 per EA |
|---|---|
| All-time high | $20.4013 (Jan 16, 2019) |
| All-time low | $1.4080 (Aug 23, 2023) |
| Median price | $3.4068 |
| Average price | $5.6696 |
| Largest weekly change | +100.9% (Mar 18, 2020) |
| Weeks tracked | 342 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Dr. Reddy's Laboratories Inc., is $2.7670 per EA (NDC 43598034530), effective Apr 30, 2025.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has declined 84.3%. It has been tracked across 342 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Oct 17, 2018, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $20.4013 (Jan 16, 2019), with a median of $3.4068 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 400 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 43598034530) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification